Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A275977-1mg | 1mg | In stock | $33.90 | |
A275977-5mg | 5mg | In stock | $140.90 | |
A275977-10mg | 10mg | In stock | $216.90 | |
A275977-25mg | 25mg | In stock | $434.90 | |
A275977-50mg | 50mg | In stock | $761.90 |
bioavailable BACE-1 inhibitor
Synonyms | 1227163-84-9|AZD3839|AZD-3839|AZD3839 free base|(S)-1-(2-(difluoromethyl)pyridin-4-yl)-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol-3-amine|AZD3839 (free base)|(1S)-1-(2-(Difluoromethyl)pyridin-4-yl)-4-fluoro-1-(3-(pyrimidin-5-yl)phenyl)-1H-isoindol- |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Potent and selective\xa0BACE-1\xa0inhibitor (K i = 26.1 nM), about 14-fold selectivity over BACE-2 (K i = 372 nM). Decreases Aβ40 levels (IC 50 = 4.8 nM) and decreases formation of sAPPβ (IC 50 = 16.7 nM). |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of beta-secretase 1 |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Shipped at 4°C. Store at -20°C. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488201265 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488201265 |
IUPAC Name | (3S)-3-[2-(difluoromethyl)pyridin-4-yl]-7-fluoro-3-(3-pyrimidin-5-ylphenyl)isoindol-1-amine |
INCHI | InChI=1S/C24H16F3N5/c25-19-6-2-5-18-21(19)23(28)32-24(18,17-7-8-31-20(10-17)22(26)27)16-4-1-3-14(9-16)15-11-29-13-30-12-15/h1-13,22H,(H2,28,32)/t24-/m0/s1 |
InChi Key | MRXBCEQZNKUUIP-DEOSSOPVSA-N |
Canonical SMILES | C1=CC(=CC(=C1)C2(C3=C(C(=CC=C3)F)C(=N2)N)C4=CC(=NC=C4)C(F)F)C5=CN=CN=C5 |
Isomeric SMILES | C1=CC(=CC(=C1)[C@@]2(C3=C(C(=CC=C3)F)C(=N2)N)C4=CC(=NC=C4)C(F)F)C5=CN=CN=C5 |
PubChem CID | 46202416 |
Molecular Weight | 431.4 |
PubChem CID | 60210951 |
---|---|
CAS Registry No. | 1227163-84-9 |
PubChem SID | 488201265 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2309188 | Certificate of Analysis | Feb 05, 2024 | A275977 |
E2309200 | Certificate of Analysis | Feb 05, 2024 | A275977 |
E2309206 | Certificate of Analysis | Feb 05, 2024 | A275977 |
E2309244 | Certificate of Analysis | Feb 05, 2024 | A275977 |
E2309238 | Certificate of Analysis | Jan 31, 2024 | A275977 |
E2309245 | Certificate of Analysis | Jan 31, 2024 | A275977 |
E2309249 | Certificate of Analysis | Jan 31, 2024 | A275977 |
E2309251 | Certificate of Analysis | Jan 31, 2024 | A275977 |
E2309254 | Certificate of Analysis | Jan 31, 2024 | A275977 |
E2309243 | Certificate of Analysis | Mar 15, 2023 | A275977 |
Solubility | Soluble in DMSO and ethanol < 200\xa0mM |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H302:Harmful if swallowed |
Precautionary Statements | P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. |
1. Jeppsson F, Eketjäll S, Janson J, Karlström S, Gustavsson S, Olsson LL, Radesäter AC, Ploeger B, Cebers G, Kolmodin K et al.. (2012) Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease.. J Biol Chem, 287 (49): (41245-57). [PMID:23048024] |